ArticleMethodsX2025
Evaluating the impact of acupuncture on perennial allergic rhinitis: A randomized placebo acupuncture control trial protocol.
Article in MethodsX, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Allergic rhinitis (AR) poses a significant global health and medical challenge. Acupuncture might serve as a therapeutic modality for allergic rhinitis, however, the empirical support for its clinical effectiveness is currently restricted.The objective of this research is to examine the therapeutic outcomes and tolerability of acupuncture treatment in the context of standard care for allergic rhinitis. Methods and analysis: A sum of 264 individuals with AR will be assigned at random to either the acupuncture (A) cohort or the placebo acupuncture (PA) cohort in an equal split of 1:1. A regimen of 12 therapeutic sessions will be conducted across a 4-week interval.The primary outcome was the 3-month post-treatment recurrence rate, assessed using the Rhinitis Control Assessment Test (RCAT) score. Additional outcomes encompass, the RQLQ, TNSS,TOSS and RMS.Participant monitoring will be conducted up to the 16th week.All participants who have been randomized will be incorporated in the analysis, with the quantitative evaluation conducted to assess the data. Ethics/dissemination: This protocol has been approved by the Research Ethical Committee of Ningxia Medical University(Permission number:Ning Medical University Ethics No.2024-3766)
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.